NeoGenomics, Inc. Interest Expense
NeoGenomics, Inc. (NEO) reported Interest Expense of $1.69 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-04-30.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-04-30
- NeoGenomics, Inc. interest expense for the quarter ending 2024-03-31 was $1.69M, a 4.10% decline year-over-year.
- NeoGenomics, Inc. interest expense for the quarter ending 2023-12-31 was $13.74M, a 163.43% increase year-over-year.
- NeoGenomics, Inc. interest expense for the quarter ending 2023-09-30 was -$2.84M, a 2143.17% decline year-over-year.
- NeoGenomics, Inc. interest expense for the quarter ending 2023-06-30 was -$2.52M, a 372.57% decline year-over-year.
- NeoGenomics, Inc. interest expense for fiscal 2023 was $6.91M, a 8.89% decline from fiscal 2022.
- NeoGenomics, Inc. interest expense for fiscal 2022 was $7.58M, a 7.77% decline from fiscal 2021.
- NeoGenomics, Inc. interest expense for fiscal 2021 was $8.22M, a 17.11% increase from fiscal 2020.
- NeoGenomics, Inc. interest expense for fiscal 2020 was $7.02M, a 89.04% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2024-03-31 | $1.69M 10-Q · filed 2024-04-30 | $15.42M derived: sum of 2 quarters · filed 2024-04-30 | $12.58M derived: sum of 3 quarters · filed 2024-04-30 | $10.06M derived: sum of 4 quarters · filed 2024-04-30 | |
| 2023-12-31 | $13.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $10.90M derived: sum of 2 quarters · filed 2024-02-20 | $8.37M derived: sum of 3 quarters · filed 2024-02-20 | $6.91M 10-K · filed 2024-02-20 | |
| 2023-09-30 | -$2.84M 10-Q · filed 2023-11-06 | -$5.36M derived: sum of 2 quarters · filed 2023-11-06 | -$6.83M 10-Q · filed 2023-11-06 | $1.61M derived: sum of 4 quarters · filed 2024-04-30 | |
| 2023-06-30 | -$2.52M 10-Q · filed 2023-08-08 | -$3.99M 10-Q · filed 2023-08-08 | $4.45M derived: sum of 3 quarters · filed 2024-04-30 | $4.59M derived: sum of 4 quarters · filed 2024-04-30 | |
| 2023-03-31 | $1.76M 10-Q · filed 2024-04-30 | $6.97M derived: sum of 2 quarters · filed 2024-04-30 | $7.11M derived: sum of 3 quarters · filed 2024-04-30 | $8.04M derived: sum of 4 quarters · filed 2024-04-30 | |
| 2022-12-31 | $5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $5.35M derived: sum of 2 quarters · filed 2024-02-20 | $6.28M derived: sum of 3 quarters · filed 2024-02-20 | $7.58M 10-K · filed 2024-02-20 | $1.51M 10-K · filed 2023-02-24 |
| 2022-09-30 | $139.00K 10-Q · filed 2023-11-06 | $1.06M derived: sum of 2 quarters · filed 2023-11-06 | $2.37M 10-Q · filed 2023-11-06 | $7.21M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-06-30 | $926.00K 10-Q · filed 2023-08-08 | $2.23M 10-Q · filed 2023-08-08 | $7.07M derived: sum of 3 quarters · filed 2024-02-20 | $8.37M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-03-31 | $1.30M 10-Q · filed 2022-05-09 | $6.15M derived: sum of 2 quarters · filed 2024-02-20 | $7.44M derived: sum of 3 quarters · filed 2024-02-20 | $8.34M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2021-12-31 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $6.14M derived: sum of 2 quarters · filed 2024-02-20 | $7.04M derived: sum of 3 quarters · filed 2024-02-20 | $8.22M 10-K · filed 2024-02-20 | $5.08M 10-K · filed 2022-02-25 |
| 2021-09-30 | $1.30M 10-Q · filed 2022-11-08 | $2.20M derived: sum of 2 quarters · filed 2022-11-08 | $3.38M 10-Q · filed 2022-11-08 | $5.57M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2021-06-30 | $902.00K 10-Q · filed 2022-08-09 | $2.08M 10-Q · filed 2022-08-09 | $4.27M derived: sum of 3 quarters · filed 2023-02-24 | $6.73M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2021-03-31 | $1.18M 10-Q · filed 2022-05-09 | $3.37M derived: sum of 2 quarters · filed 2023-02-24 | $5.83M derived: sum of 3 quarters · filed 2023-02-24 | $7.38M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2020-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $4.65M derived: sum of 2 quarters · filed 2023-02-24 | $6.20M derived: sum of 3 quarters · filed 2023-02-24 | $7.02M 10-K · filed 2023-02-24 | |
| 2020-09-30 | $2.46M 10-Q · filed 2021-11-04 | $4.01M derived: sum of 2 quarters · filed 2021-11-04 | $4.83M 10-Q · filed 2021-11-04 | $5.21M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | $1.55M 10-Q · filed 2021-08-09 | $2.37M 10-Q · filed 2021-08-09 | $2.75M derived: sum of 3 quarters · filed 2022-02-25 | $2.95M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $819.00K 10-Q · filed 2021-05-06 | $1.20M derived: sum of 2 quarters · filed 2022-02-25 | $1.40M derived: sum of 3 quarters · filed 2022-02-25 | $2.71M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $380.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $583.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.89M derived: sum of 3 quarters · filed 2022-02-25 | $3.71M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $203.00K 10-Q · filed 2020-10-29 | $1.51M derived: sum of 2 quarters · filed 2020-10-29 | $3.33M 10-Q · filed 2020-10-29 | $4.80M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $1.30M 10-Q · filed 2020-07-31 | $3.13M 10-Q · filed 2020-07-31 | $4.59M derived: sum of 3 quarters · filed 2021-02-25 | $6.47M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $1.83M 10-Q · filed 2020-04-29 | $3.29M derived: sum of 2 quarters · filed 2021-02-25 | $5.16M derived: sum of 3 quarters · filed 2021-02-25 | $6.57M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.34M derived: sum of 2 quarters · filed 2021-02-25 | $4.74M derived: sum of 3 quarters · filed 2021-02-25 | $6.23M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $1.87M 10-Q · filed 2019-11-13 | $3.28M derived: sum of 2 quarters · filed 2019-11-13 | $4.77M 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $1.41M 10-Q · filed 2019-08-07 | $2.89M 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | $1.49M 10-Q · filed 2019-05-08 | ||||
| 2017-12-31 | $5.54M 10-K · filed 2020-02-28 | ||||
| 2015-12-31 | $854.00K 10-K · filed 2016-04-18 | ||||
| 2014-12-31 | $985.00K 10-K · filed 2016-04-18 | ||||
| 2014-03-31 | $265.00K 10-Q · filed 2014-05-12 | $505.00K derived: sum of 2 quarters · filed 2016-04-18 | $736.00K derived: sum of 3 quarters · filed 2016-04-18 | $968.00K derived: sum of 4 quarters · filed 2016-04-18 | |
| 2013-12-31 | $240.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-18 | $471.00K derived: sum of 2 quarters · filed 2016-04-18 | $703.00K derived: sum of 3 quarters · filed 2016-04-18 | $989.00K 10-K · filed 2016-04-18 | |
| 2013-09-30 | $231.00K 10-Q · filed 2013-10-30 | $463.00K derived: sum of 2 quarters · filed 2013-10-30 | $749.00K 10-Q · filed 2013-10-30 | $1.06M derived: sum of 4 quarters · filed 2014-05-12 | |
| 2013-06-30 | $232.00K 10-Q · filed 2013-08-02 | $517.00K 10-Q · filed 2013-08-02 | $826.00K derived: sum of 3 quarters · filed 2014-05-12 | $1.12M derived: sum of 4 quarters · filed 2014-05-12 | |
| 2013-03-31 | $285.00K 10-Q · filed 2014-05-12 | $594.00K derived: sum of 2 quarters · filed 2014-05-12 | $885.00K derived: sum of 3 quarters · filed 2014-05-12 | $1.17M derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | $309.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $600.00K derived: sum of 2 quarters · filed 2014-02-24 | $888.00K derived: sum of 3 quarters · filed 2014-02-24 | $1.15M 10-K · filed 2014-02-24 | |
| 2012-09-30 | $291.00K 10-Q · filed 2013-10-30 | $579.00K derived: sum of 2 quarters · filed 2013-10-30 | $837.00K 10-Q · filed 2013-10-30 | $1.06M derived: sum of 4 quarters · filed 2014-02-24 | |
| 2012-06-30 | $288.00K 10-Q · filed 2013-08-02 | $546.00K 10-Q · filed 2013-08-02 | $769.00K derived: sum of 3 quarters · filed 2014-02-24 | $954.00K derived: sum of 4 quarters · filed 2014-02-24 | |
| 2012-03-31 | $258.00K 10-Q · filed 2013-05-13 | $481.00K derived: sum of 2 quarters · filed 2014-02-24 | $666.00K derived: sum of 3 quarters · filed 2014-02-24 | $845.00K derived: sum of 4 quarters · filed 2014-02-24 | |
| 2011-12-31 | $223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $408.00K derived: sum of 2 quarters · filed 2014-02-24 | $587.00K derived: sum of 3 quarters · filed 2014-02-24 | $768.00K 10-K · filed 2014-02-24 | |
| 2011-09-30 | $185.00K 10-Q · filed 2012-11-05 | $364.00K derived: sum of 2 quarters · filed 2012-11-05 | $545.00K 10-Q · filed 2012-11-05 | ||
| 2011-06-30 | $179.00K 10-Q/A · filed 2012-08-15 | $361.00K 10-Q/A · filed 2012-08-15 | |||
| 2011-03-31 | $182.00K 10-Q · filed 2012-05-14 | ||||
| 2010-12-31 | $710.00K 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |